Nureca P/B Ratio
Nureca (NURECA) P/B ratio is 1.3 (Moderate), book value per share ₹194.00 vs Healthcare average P/B of -0.94 — Moderate - Reasonably valued relative to book value. For live price, earnings yield and the full fundamental profile, see NURECA screener.
Current Valuation Metrics
Book Value Breakdown (2025)
Valuation Signal
Sector Context
NURECA P/B Ratio — Valuation Insights & Book Value Analysis
Nureca price-to-book ratio interpretation, valuation status and historical context — current P/B 1.3 (Moderate). Compare with NURECA fair value to assess whether the stock is under or overvalued.
- Current PB is 67.5% below historical average
- Trading at premium to sector average PB of -0.94
Nureca P/B Ratio Historical Trend
NURECA annual price-to-book ratio — 5 years, book value per share and year-end price. P/B below 1.0 indicates the stock trades below net asset value. View NURECA price range for the annual high/low range and current price position.
NURECA Historical P/B Ratio — Book Value Per Share & Year-End Price
Nureca annual P/B ratio, book value per share (₹), year-end price and total equity in ₹ Crores.
| Year | P/B Ratio | Book Value/Share (₹) | Year-end Price (₹) | Total Equity (₹ Cr) | Valuation |
|---|---|---|---|---|---|
| 2025 | 1.59 | ₹194.0 | ₹307.95 | ₹194 | Moderate |
| 2024 | 1.47 | ₹193.0 | ₹282.95 | ₹193 | Moderate |
| 2023 | 2.19 | ₹195.0 | ₹427.90 | ₹195 | Moderate |
| 2022 | 2.45 | ₹203.0 | ₹498.15 | ₹203 | Moderate |
| 2021 | 12.3 | ₹163.0 | ₹2005.00 | ₹163 | High |
NURECA vs Healthcare Peers — P/B Ratio Comparison
Nureca P/B 1.3 vs Healthcare average -0.94, median 0.6 — range -31.21–1.03.
| Company | Symbol | P/B Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Rekvina Laboratories | VINRKLB | -31.21 | ₹25 | Low |
| Sun Pharma Advanced Rese… | SPARC | -16.05 | ₹5,310 | Low |
| Span Divergent | SDL | -6.32 | ₹19 | Low |
| Oxygenta Pharmaceutical | OXYGENTAPH | -5.54 | ₹203 | Low |
| Satiate Agri | SATAGRI | -3.39 | ₹8 | Low |
| Adline Chem Lab | ADLINE | -3.03 | ₹5 | Low |
| Bharat Immunologicals | BIBCL | -2.31 | ₹75 | Low |
| Parmax Pharma | PARMAX | -2.16 | ₹12 | Low |
| Krebs Biochemicals & Ind… | KREBSBIO | -0.76 | ₹121 | Low |
| Cresanto Global | CRESANTO | -0.7 | ₹2 | Low |